Nathaniel W Mabe Selected Research

Breast Neoplasms (Breast Cancer)

11/2020	G9a Promotes Breast Cancer Recurrence through Repression of a Pro-inflammatory Program.
10/2020	Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence.
1/2020	RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.
10/2018	Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathaniel W Mabe Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 10/2018
4	Breast Neoplasms (Breast Cancer) 11/2020 - 10/2018
2	Neuroblastoma 10/2022 - 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Vaccinia 10/2022
1	Glioma (Gliomas) 10/2022
1	Residual Neoplasm 10/2020
1	Necrosis 01/2020
1	Ischemia 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2018
2	Phosphotransferases (Kinase)IBA 10/2022 - 01/2020
1	Proto-Oncogene Proteins c-etsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Histone MethyltransferasesIBA 11/2020
1	Cystine (L-Cystine)IBA 01/2020
1	CollagenIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2022 - 10/2020
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 10/2018